ROIVANT SCIENCES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.5 USD | +1.50% |
|
+2.59% | +2.40% |
| 05/04 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
| 04/04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 913.02Cr | - | |||||
| 59TCr | ||||||
| 36TCr | ||||||
| 33TCr | ||||||
| 29TCr | ||||||
| 24TCr |
